Transarterial Radioembolization Versus Chemoembolization for Unresectable Large Single Hepatocellular Carcinoma
Open Access
- 1 January 2026
- journal article
- research article
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (10) , 961-972
Abstract
Lee M, et al. Korean J Radiol. 2026 ;27:e93. https://doi.org/10.3348/kjr.2026.0458Keywords
This publication has 24 references indexed in Scilit:
- BCLC strategy for prognosis prediction and treatment recommendations: The 2026 updateJournal of Hepatology, 2025
- Transarterial Radioembolization with Yttrium-90 and SIRT Versus Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysisAcademic Radiology, 2025
- High-Dose Radioembolization Limited by Lung Shunt for Hepatocellular Carcinoma Supplied by the Inferior Phrenic ArteryJournal of Vascular and Interventional Radiology, 2025
- TACE vs. TARE for HCC ≥ 8 cm: A propensity score analysisAbdominal Radiology, 2024
- Radiation Major Hepatectomy Using Ablative Dose Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma 5 cm or LargerJournal of Vascular and Interventional Radiology, 2023
- Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cmJournal of Vascular and Interventional Radiology, 2019
- Yttrium-90 Radioembolization of the Right Inferior Phrenic Artery in 20 Patients with Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2018
- Elevated Lung Shunt Fraction as a Prognostic Indicator for Disease Progression and Metastasis in Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2016
- Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With ChemoembolizationClinical Gastroenterology and Hepatology, 2013
- Chemoembolization for the Treatment of Large Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2010